|
市場調査レポート
商品コード
1446183
高性能バイオ材料の世界市場 2024-2028Global High Performance Biomaterials Market 2024-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
高性能バイオ材料の世界市場 2024-2028 |
出版日: 2024年02月13日
発行: TechNavio
ページ情報: 英文 183 Pages
納期: 即納可能
|
高性能バイオ材料市場は2023-2028年に84億8,000万米ドル、予測期間中のCAGRは11.29%で成長すると予測されます。
当レポートでは、高性能バイオ材料市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、筋骨格系疾患および障害の有病率の増加、歯科疾患および関連リスク要因の有病率の上昇、人工関節置換術および関節形成術の急増によって牽引されています。
市場範囲 | |
---|---|
基準年 | 2024 |
終了年 | 2028 |
予測期間 | 2024-2028 |
成長モメンタム | 加速 |
前年比2024年 | 10.21% |
CAGR | 11.29% |
増分額 | 84億8,000万米ドル |
本調査では、今後数年間の高性能バイオ材料市場成長を牽引する主な要因の一つとして、組織工学における高性能バイオ材料の開発を挙げています。また、再生医療に関する先進的な調査やドラッグデリバリーシステムの進歩も市場の大きな需要につながります。
Exhibits:
The high performance biomaterials market is forecasted to grow by USD 8.48 bn during 2023-2028, accelerating at a CAGR of 11.29% during the forecast period. The report on the high performance biomaterials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of musculoskeletal diseases and disorders, rising prevalence of dental diseases and related risk factors, and surging number of joint replacement and arthroplasty surgeries.
Technavio's high performance biomaterials market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 10.21% |
CAGR | 11.29% |
Incremental Value | $8.48bn |
By Type
By Application
By Geographical Landscape
This study identifies the development of high-performance biomaterials in tissue engineering as one of the prime reasons driving the high performance biomaterials market growth during the next few years. Also, progressive research on regenerative medicine and advancements in drug delivery systems will lead to sizable demand in the market.
The report on the high performance biomaterials market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading high performance biomaterials market vendors that include Advanced Medical Solutions Group Plc, Arctic Biomaterials Oy Ltd, BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, CoorsTek Inc., Corbion nv, Covestro AG, Dentsply Sirona Inc., Evonik Industries AG, Himed LLC, Honeywell International Inc., Koninklijke DSM NV, Regenity Biosciences, RevBio Inc., Solesis, Stryker Corp., Victrex Plc, Zimmer Biomet Holdings Inc., and ZimVie Inc.. Also, the high performance biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.